Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer

Go back to Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer
(NASDAQ: PLRX) Delayed: 1.17 +0.06 (5.41%)
Previous Close $1.11    52 Week High
Open $1.11    52 Week Low
Day High $1.18    P/E N/A 
Day Low $1.11    EPS
Volume 702,120